. FDA Authorizes Eli Lilly’s Covid-19 Antibody Treatment For Emergency Use « JO LEE MAGAZINE

NBC – The Food and Drug Administration has granted an emergency use authorization for Eli Lilly’s Covid-19 monoclonal antibody treatment, called bamlanivimab.

The FDA action specifies that the therapy is meant for adults and children over age 12 with mild to moderate illness but who have high risks of getting much worse and needing hospitalization. That includes…

More at NBC

Comments are closed.